CRDF
Cardiff Oncology Inc

18,782
Mkt Cap
$214.21M
Volume
1.17M
52W High
$4.99
52W Low
$1.90
PE Ratio
-3.99
CRDF Fundamentals
Price
$3.17
Prev Close
$3.18
Open
$3.09
50D MA
$2.30
Beta
1.38
Avg. Volume
743,059.11
EPS (Annual)
-$0.9539
P/B
4.36
Rev/Employee
$20,696.97
Loading...
Loading...
News
all
press releases
Stock Traders Purchase High Volume of Cardiff Oncology Call Options (NASDAQ:CRDF)
Cardiff Oncology, Inc. (NASDAQ:CRDF - Get Free Report) was the target of unusually large options trading on Tuesday. Traders purchased 2,314 call options on the stock. This represents an increase of...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Flputnam Investment Management Co. Purchases 543,370 Shares of Cardiff Oncology, Inc. $CRDF
Flputnam Investment Management Co. lifted its position in Cardiff Oncology, Inc. (NASDAQ:CRDF - Free Report) by 1,008.8% during the 3rd quarter, according to the company in its most recent Form 13F...
MarketBeat·4d ago
News Placeholder
Cardiff Oncology, Inc. (NASDAQ:CRDF) Given Average Rating of "Hold" by Brokerages
Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF - Get Free Report) have been given an average recommendation of "Hold" by the five analysts that are currently covering the firm, MarketBeat reports. One...
MarketBeat·10d ago
News Placeholder
FY2025 Earnings Forecast for CRDF Issued By Zacks Small Cap
Cardiff Oncology, Inc. (NASDAQ:CRDF - Free Report) - Zacks Small Cap issued their FY2025 earnings per share (EPS) estimates for shares of Cardiff Oncology in a report issued on Tuesday, December 9th...
MarketBeat·16d ago
News Placeholder
Cardiff Oncology, Inc. (NASDAQ:CRDF) Given Consensus Rating of "Moderate Buy" by Brokerages
Cardiff Oncology, Inc. (NASDAQ:CRDF - Get Free Report) has earned an average recommendation of "Moderate Buy" from the six analysts that are presently covering the stock, MarketBeat Ratings reports...
MarketBeat·1mo ago
News Placeholder
What is HC Wainwright's Estimate for CRDF FY2025 Earnings?
Cardiff Oncology, Inc. (NASDAQ:CRDF - Free Report) - Equities researchers at HC Wainwright upped their FY2025 earnings estimates for Cardiff Oncology in a note issued to investors on Wednesday...
MarketBeat·1mo ago
News Placeholder
Cardiff Oncology (NASDAQ:CRDF) Issues Quarterly Earnings Results
Cardiff Oncology (NASDAQ:CRDF - Get Free Report) released its earnings results on Thursday. The company reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.20...
MarketBeat·2mo ago
News Placeholder
Cardiff Oncology (CRDF) Reports Q2 Loss, Lags Revenue Estimates
Cardiff Oncology (CRDF) delivered earnings and revenue surprises of -10.53% and -19.33%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5mo ago
News Placeholder
Cardiff Oncology (CRDF) Upgraded to Buy: Here's What You Should Know
Zacks·8mo ago
News Placeholder
Cardiff Oncology (CRDF) Reports Q1 Loss, Lags Revenue Estimates
chainwire·8mo ago
<
1
2
...
>

Latest CRDF News

View

Advertisement|Remove ads.

Advertisement|Remove ads.